Drugs that contain Ferumoxytol
1. Feraheme patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8926947 | COVIS | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
Mar, 2020
(4 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8501158 | COVIS | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
Mar, 2020
(4 years ago) | |
| US8591864 | COVIS | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
Mar, 2020
(4 years ago) | |
| US6599498 | COVIS | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives |
Mar, 2020
(4 years ago) | |
| US7553479 | COVIS | Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
Mar, 2020
(4 years ago) | |
| US7871597 | COVIS | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
Mar, 2020
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jun 30, 2012 |
| New Indication(I-767) | Feb 02, 2021 |
Market Authorisation Date: 30 June, 2009
Treatment: Method of treating patients needing an iron supplement
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of FERAHEME before it's drug patent expiration?
More Information on Dosage
FERAHEME family patents
